Ridge Preservation Comparing an Intrasocket Graft Alone to an Intrasocket Graft Plus a Facial Overlay Graft
Launched by UNIVERSITY OF LOUISVILLE · Sep 8, 2011
Trial Information
Current as of July 06, 2025
Completed
Keywords
ClinConnect Summary
Subjects met the eligibility criteria if they were at least 18 years of age and had one nonmolar tooth requiring extraction that would be replaced by a dental implant. Extraction sites were bordered by at least one tooth. Exclusion criteria included: 1) debilitating systemic diseases, or diseases that have a clinically significant effect on the periodontium; 2) molar extraction sites; 3) presence of or history of osteonecrosis of the jaws; 4) history of IV bisphosphonate treatment; 5) history of oral bisphosphonate treatment for more than three years; 6) pregnancy or lactation; 7) known all...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Have one non-molar tooth requiring extraction that will be replaced by a dental implant. The site must be bordered by at least one tooth.
- • 2. Healthy person that is at least 18 years old.
- • 3. Patients must sign an informed consent approved by the University of Louisville Human Studies Committee.
- Exclusion Criteria:
- • 1. Patients with debilitating systemic diseases, or diseases that have a clinically significant effect on the periodontium.
- • 2. Molar teeth.
- • 3. Presence of or history of osteonecrosis of the jaws.
- • 4. Patients who are currently taking IV bisphosphonates or who had IV treatment with bisphosphonates irrespective of the duration.
- • 5. Patients who have been treated with oral bisphosphonates for more than three years.
- • 6. Pregnant women due to the possibility of miscarriage.
- • 7. Patients with an allergy to any material or medication used in the study.
- • 8. Patients who need prophylactic antibiotics.
- • 9. Previous head and neck radiation therapy.
- • 10. Chemotherapy in the previous 12 months.
- • 11. Patients on long term NSAID or steroid therapy.
About University Of Louisville
The University of Louisville is a distinguished academic institution known for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct pioneering studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on interdisciplinary collaboration and community engagement, the University of Louisville fosters an environment conducive to groundbreaking research across various medical fields, ensuring adherence to the highest ethical standards and regulatory compliance. Through its clinical trials, the university seeks to translate scientific discoveries into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Louisville, Kentucky, United States
Patients applied
Trial Officials
Henry Greenwell, DMD
Principal Investigator
University of Louisville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials